Virginia Small Business Financing Authority (MEDXF)
OTC PINK OTC PINK Primary 
Medexus Pharmaceuticals Inc. (MEDXF) Q1 2026 Earnings Call Transcript
Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q1 2026 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Brendon Buschman - Chief Financial Officer Kenneth d'Entremont - CEO & Director Victoria Rutherford - Corporate Participant Conference Call Participants Andre Uddin - Research Capital Corporation, Research Division Gireesh Seesankar - Bloom Burton & Co., Research Division Michael W. Freeman - Raymond James & Associates, Inc., Research Division Scott Robert Henry - Alliance Global Partners, Research Division Operator Good morning, everyone, and welcome to the Medexus Pharmaceuticals First Quarter 2026 Conference Call.
Medexus Pharmaceuticals Inc. (MEDXF) Q4 2025 Earnings Call Transcript
Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q4 2025 Earnings Conference Call June 26, 2025 8:00 AM ET Company Participants Brendon Buschman - Chief Financial Officer Kenneth d'Entremont - CEO & Director Conference Call Participants Andre Uddin - Research Capital Corporation, Research Division David C. Martin - Bloom Burton & Co., Research Division Michael W.
Medexus Pharmaceuticals, Inc. (MEDXF) Q3 2025 Earnings Call Transcript
Medexus Pharmaceuticals, Inc. (OTCQX:MEDXF) Q3 2025 Earnings Conference Call February 6, 2025 8:00 AM ET Company Participants Victoria Rutherford - IR, Adelaide Capital Ken d'Entremont - CEO Brendon Buschman - CFO Conference Call Participants Michael Freeman - Raymond James David Martin - Bloom Burton Scott Henry - Alliance Global Partners Operator Good morning, everyone. Welcome to the Medexus Pharmaceuticals Third Quarter 2025 Conference Call.
Medexus Pharmaceuticals Inc. (MEDXF) Q2 2025 Earnings Call Transcript
Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q2 2025 Earnings Conference Call November 8, 2024 8:00 AM ET Company Participants Victoria Rutherford - IR, Adelaide Capital Ken d'Entremont - CEO Brendon Bushman - CFO Conference Call Participants Andre Uddin - Research Capital Michael Freeman - Raymond James Max Czmielewski - Ventum Capital Markets Justin Keywood - Stifel Operator Good morning everyone and welcome to the Medexus Pharmaceuticals Second Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode and we will open for questions following the presentation.
Medexus Pharmaceuticals Inc. (MEDXF) Q4 2024 Earnings Call Transcript
Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q4 2024 Earnings Conference Call June 26, 2024 8:00 AM ET Company Participants Victoria Rutherford - IR, Adelaide Capital Kenneth d'Entremont - CEO Marcel Konrad - CFO Conference Call Participants Andre Uddin - Research Capital Michael Freeman - Raymond James David Martin - Bloom Burton Stefan Quenneville - Echelon Capital Markets Julian Hung - Stifel Operator Good morning, everyone, and welcome to the Medexus Pharmaceuticals Fourth Fiscal Quarter and 2024 Fiscal Year Conference Call. At this time, all participants are in a listen-only mode, and we will be opening for questions following the presentation.
